Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2. (Q35875096)
Jump to navigation
Jump to search
scientific article published in December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2. |
scientific article published in December 2010 |
Statements
1 reference
Two-year safety and virologic efficacy of maraviroc in treatment-experienced patients with CCR5-tropic HIV-1 infection: 96-week combined analysis of MOTIVATE 1 and 2. (English)
1 reference
Gerd Fätkenheuer
1 reference
W David Hardy
1 reference
Roy M Gulick
1 reference
Howard Mayer
1 reference
Mark Nelson
1 reference
Jayvant Heera
1 reference
Natasa Rajicic
1 reference
James Goodrich
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference